| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |